866.776.5907         
Home
866.776.5907
  • DIAGNOSTIC SERVICES 

    New Tests

    Test Methodologies  

    Cytogenetics FISH Flow Cytometry IHC & ISH Molecular

    Specialty Testing  

    Hemopathology
    Overview NeoCOMPLETETM
    Solid Tumors
    Overview Cancer TYPE ID®
    Immuno-oncology
    NeoTYPE® Cancer Profiles  
    Overview NeoTYPE® Cancer Specific Profiles NeoTYPE® Broad Reach Tumor Profiles
    NeoLAB™ Liquid Biopsy  
    Overview NeoLAB™ Liquid Biopsy for Hematologic Diseases NeoLAB™ Solid Tumor Monitor NeoLAB™ EGFR T790M Liquid Biopsy
    NCI-MATCH Pediatric Oncology Hereditary Cancer

    Test Spotlight

    Tech-Only Program  

    Overview Virtual HemeFISH®

    Getting Started With NeoGenomics

  • PHARMA SERVICES 

    Pharma Services  

    Overview Ordering Logistics Blog: Pharma Services Insights

    Why Choose NeoGenomics  

    Overview Global Capabilities Expertise

    Lab Services  

    Overview Anatomic Pathology Cytogenetics FISH Flow Cytometry Molecular MultiOmyx™

    IVD Services

    Healthcare Information Services

    Request More Information

  • TEST MENU
  • CLIENT SERVICES 

    Test Ordering & Pickup  

    Overview Forms & Kits Specimen Pickup Online Ordering

    Education   

    Powering Precision: A Blog NeoUniversity™ Publications, Abstracts, and Posters On-Demand Webinars

    Billing 

    Client Billing Patient Billing Third Party Billing Prior Authorization
  • COMPANY 

    Overview

    Leadership 

    Leadership Team Medical & Scientific Team Scientific Advisory Board

    Careers  

    Overview Benefits

    Events

    Investors

    Press Releases

    Newsletter

    Regulatory

    Contact Us

  • 0 Search
  • NeoLink ® Log In
Home        
  • Diagnostic Services
    • New Tests
    • Test Methodologies
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • IHC & ISH
      • Molecular
    • Specialty Testing
      • Hematopathology
        • Overview
        • NeoCOMPLETETM
      • Solid Tumors
        • Overview
        • CancerTYPE ID®
      • Immuno-Oncology
      • Cancer Profiles
        • Overview
        • NeoTYPE ® Cancer-Specific Profiles
        • NeoTYPE ® Broad Reach Tumor Profiles
      • NeoLAB™ Liquid Biopsy
        • Overview
        • NeoLAB™ Liquid Biopsy for Hematologic Diseases
        • NeoLAB™ Solid Tumor Monitor
        • NNeoLAB™ EGFR T790M Liquid Biopsy
      • NCI-MATCH
      • Pediatric Oncology
      • Hereditary Cancer
    • Test Spotlight
    • Tech-Only Program
      • Overview
      • Virtual HemeFISH ®
    • Get Started with NeoGenomics
  • Pharma Services
    • Overview
      • Overview
      • Ordering Logistics
      • Pharma Services Insights
    • Why Choose NeoGenomics?
      • Overview
      • Global Capabilities
      • Expertise
    • Lab Services
      • Overview
      • Overview
      • Cytogenetics
      • FISH
      • Flow Cytometry
      • Molecular
      • MultiOmyx™
    • IVD Services
    • Healthcare Information Services
    • Request More Information
  • Test Menu
  • Client Services
    • Overview
    • Test Ordering and Pickup
      • Overview
      • Forms and Kits
      • Specimen Pick-Up
      • Online Ordering
    • Education
      • Powering Precision: A Blog
      • NeoUniversity™
      • Publications, Abstracts and Posters
      • On-Demand Webinars
    • Billing
      • Client Billing
      • Patient Billing
      • Third Party Billing
      • Prior Authorization
  • Company
    • Overview
    • Leadership
      • Leadership Team
      • Medical and Scientific Team
      • Scientific Advisory Board
    • Careers
      • Overview
      • Benefits
    • Events
    • Investors
    • Press Releases
    • Newsletter
    • Regulatory and Licensing
    • Contact Us
NEOLINK® LOGIN
Investors
  • IR Overview
  • News / Events / Webcasts
    • Overview
    • Presentations
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Executive Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

Investor Relations

  • IR Overview
  • News / Events / Webcasts
    • Presentations
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • Overview
  • Presentations
  • Press Releases
  • IR Calendar
  • Email Alerts

NeoGenomics to Host Investor Day on April 4, 2023

Mar 27, 2023

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

Mar 16, 2023

NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP

Mar 13, 2023

NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference

Feb 28, 2023

NeoGenomics Reports Fourth Quarter and Full Year 2022 Results

Feb 23, 2023

NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023

Feb 6, 2023

RaDaR® Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery

Feb 6, 2023

NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 5, 2022

NeoGenomics Announces Chief Financial Officer Transition

Dec 5, 2022

RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease

Nov 21, 2022
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...24

© 2023 NeoGenomics Laboratories, Inc.

Contact Us | Careers | Licensing | Terms | Privacy

sfy39587stp16